NEW YORK, Oct 3 – In the midst of an intellectual property battle with Affymetrix (Nasdaq: AFFX) over a non-PCR based RNA technology that researchers use in microarray-based gene expression analysis, Incyte Genomics (Nasdaq: INCY) said Tuesday it had licensed the related patents to American Home Products (NYSE: AHP) for internal use with Affy’s GeneChips.

AHP, a Madison, NJ-based pharmaceutical company, is also a subscriber to Incyte’s LifeSeq gene sequence database.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.